This multicenter, prospective, longitudinal, observational study in approximately 80 subjects with Stargardt disease secondary to biallelic mutations in the ABCA4 gene (STGD1) aims to evaluate prognostic factors of disease progression, and to further characterize the patient population for future clinical studies.
Study Type
OBSERVATIONAL
Enrollment
80
Retina Foundation of the Southwest
Dallas, Texas, United States
RECRUITINGOslo University hospital Ullevål
Oslo, Norway
RECRUITINGTo measure the change from baseline in Fundus Autofluorescence
Time frame: 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.